Table 2

Healthcare providers’ best estimate of how many of their patients would switch to a novel long-acting HIV treatment (n=120), 2019

CharacteristicsCategoryNHCP estimate of what percentage of their patients would actually switch to LAR (regimen Z)
Estimated proportion of patients (unadjusted)Incidence rate ratio (adjusted)
Total25.7
HCP genderFemale (referent)3721.61.00 (referent)
Male7927.2 1.25 (1.16 to 1.36)
Unknown4**
HCP specialtyHIV/AIDS (referent)4423.9
Infectious disease6725.31.02 (0.94 to 1.12)
Other936.4 1.47 (1.29 to 1.67)
Years of practice≤15 (referent)4725.9
16–203925.81.02 (0.93 to 1.11)
21–313425.20.96 (0.87 to 1.06)
Number of patients<220 (referent)4830.7
220–3503423.7 0.80 (0.73 to 0.87)
>3503820.9 0.75 (0.68 to 0.83)
RankProfessor/Consultant (referent)6423.0
Associate/Registrar5628.7 1.30 (1.18 to 1.43)
Practice settingTeaching/Specialist hospital (referent)3627.8
General hospital4426.9 0.68 (0.58 to 0.80)
Other4022.5 0.71 (0.63 to 0.80)
Percentage of patients that are non-European<20% (referent)8127.2
≥20%3922.4 0.80 (0.72 to 0.88)
Proportion of patients that identify as non-heterosexual<50% (referent)8025.9
≥50%4025.21.02 (0.93 to 1.11)
Location of HCP practiceMetropolitan (referent)6927.3
Urban (non-metropolitan)3922.1 0.84 (0.77 to 0.91)
Other/unknown1228.2 1.24 (1.09 to 1.41)
CountryFrance (referent)3029.6
Germany3030.50.99 (0.90 to 1.10)
Italy3025.1 0.85 (0.77 to 0.94)
UK3017.6 0.58 (0.52 to 0.65)
Percentage of patients with malabsorption≤10% (referent)8923.5
>10%3131.9 1.38 (1.27 to 1.50)
Percentage of patients with dysphagia≤10% (referent)8724.4
>10%3329.0 1.20 (1.11 to 1.31)
Percentage of patients with gastrointestinal condition interfering with oral intake≤10% (referent)8423.3
>10%3631.1 1.24 (1.15 to 1.34)
Percentage of patients with CNS disorder≤10% (referent)8222.1
>10%3833.3 1.60 (1.48 to 1.74)
  • Because of collinearity, each independent variable was analysed separately, adjusting for years of practice, gender and country of residence. Estimates in bold were statistically significant at p < 0.05.

  • *Estimates suppressed because of small sample size.

  • CNS, central nervous system; HCP, healthcare provider; LAR, long-acting regimen.